CONMED

Utica, United States Founded: 1987 • Age: 39 yrs Listed
Surgical instruments are manufactured for multiple therapeutic areas.

About CONMED

CONMED is a publicly listed company based in Utica (United States) founded in 1987 by Eugene Corasanti. Surgical instruments are manufactured for multiple therapeutic areas. The company has 3,900 employees. CONMED has completed 7 acquisitions, including Buffalo Filter, In2Bones and In2Bones USA. Its chief executive, as recorded, is Curt Hartman. Its website conmed.com draws about 77 thousand monthly visits. Its Indian entity Linvatec India Private Limited reported revenue of ₹44.33 Cr. CONMED offers products and services including AirSeal, BioBrace, and Argo Knotless. Its focus areas include Diversified Medical Devices and Devices. Its competitors include GE Healthcare, Medtronic and Boston Scientific; 1 of its 3 listed competitors has raised funding.

Company details

CONMED was established in 1987 in Utica, United States, as a medical device company. Emphasis is placed on research and development for manufacturing surgical instruments and equipment used in minimally invasive procedures. Products are applied across specialties including general surgery, urology, gynecology, colorectal, and gastroenterology. Operations center on supporting surgeons and physicians with tools for various therapeutic needs.

Key Metrics
  • Indian entity revenue
    ₹44.33 Cr

    FY 2024 · +38% YoY

  • Indian entity net profit
    ₹1.23 Cr

    FY 2024 · 3% margin

  • Indian entity EBITDA
    ₹4.07 Cr

    FY 2024 · 9% margin

  • Latest Funding Round
    $345M (USD), Post-IPO

    Mar 2019

  • Investors
    Barclays

    & 1 more

  • Employee Count
    3,900
  • Investments & Acquisitions

Products & Services of CONMED

CONMED offers a comprehensive portfolio of products and services, including AirSeal, BioBrace, and Argo Knotless.

AirSeal
Insufflation System

Maintains stable pressure for laparoscopic and robotic surgeries

BioBrace
Biocomposite Implant

Reinforces tendons and ligaments in orthopedic procedures

Argo Knotless
Suture Anchor

Adjusts tension for secure surgical fixation

Apps and channels of CONMED

its YouTube channel CONMED has 137K subscribers and 30 videos.

CONMED
YouTube 137K subscribers 30 videos Science & Technology
Open channel

Videos from CONMED

The most watched videos on CONMED's YouTube channel, CONMED (137K subscribers). Click a video to play it here.

AirSeal® Clinical Insufflation: A Transformation in Early Recovery After Surgery - CONMED
1.8K views
BioBrace®RC for Augmentation of a Rotator Cuff Repair - CONMED Animation
1.5K views
Dr. Dustin Constant - Lateral Ankle Stabilization Using BioBrace and TruShot Anchors - Technique
889 views
HydroSeal™ Silicone Cannula - CONMED Product Video
617 views

More on CONMED.

Funding Insights of CONMED

  • Total Rounds 2
  • Last Round Post-IPO — $345M
  • First Round $150M

    (Nov 2004)

  • Investors Count 2

All 2 funding rounds of CONMED with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2019$345MPost-IPO––
Nov 2004$150MPost-IPO––
–
Valuation history

2 investors in total: 2 institutional.

Investors in CONMED

CONMED has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Barclays and J P Morgan Wealth Management.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Provides banking, credit cards, investments, loans, and auto financing services.
1985jpmorganwealthmanagement.comNew York, United States
Diversified financial services are provided across global markets.
1690home.barclaysLondon, United Kingdom
Premium access

Investor details for CONMED

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Linvatec India Private Limited (CONMED)

Linvatec India Private Limited is the primary company behind CONMED. The board of Linvatec India Private Limited currently have 3 directors; the longest-serving is Johonna Pelletier, appointed in 2018. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Johonna Pelletier
DIN 08272286
Director01 Nov 20188 yrsLinvatec India Private Limited
Vishal Verma
DIN 08992036
Director10 Dec 20205 yrs 10 moLinvatec India Private Limited
Stephane Jean Epinette
DIN 11008271
Additional Director19 Mar 20251 yr 7 moLinvatec India Private Limited

People of CONMED

69 people are tracked at CONMED (22 in leadership, 8 in board & advisors, 39 in team); the tracked headcount is 3,900.

NameRoleGroup
Eugene Corasanti
FounderLeadership
Curt Hartman
CEO & PresidentLeadership
Jorge Mario Suarez Bohorquez
Director Finance & Commercial Operations - Latin AmericaLeadership
Jeff Abbas
Director Of Finance, Innovative Solutions GroupLeadership
Treasurer and Vice President, TaxLeadership
Justin Shepherd
Director Of Fp&a And Financial SystemsLeadership
Todd W. Garner
EVP and CFOLeadership
John Conaton
Vice President FinanceLeadership
Brad Lukey
Senior Director, Finance & Commercial OperationsLeadership
Taylor Martin
Director Business Analytics, OperationsLeadership
Greg S.
Vp, Head Of Internal AuditLeadership
Manuel de Sousa
Vice President Finance, InternationalLeadership
Alex Siulc
VP Finance Advanced SurgicalLeadership
Steve Foy
VP Of Finance- Operations, QA & RALeadership
Richard Viviano
Senior Sales Finance Business PartnerLeadership
Moon Lee
Finance Director - Asia-pacificLeadership
Yuliya Cudia
Director Of Finance, International OperationsLeadership
Jamie Kern
Director, Finance - Innovative Solutions GroupLeadership
Kim Lockwood
Director Of Financial Reporting & ControlsLeadership
Lisa Fedczuk
Working Capital DirectorLeadership

49 more people are available in the full profile.

Premium access

Complete people profiles for CONMED

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of CONMED

CONMED is a publicly listed company on the NYSE with ticker symbol CNMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date24 Jul 1987
  • Listed onNYSE: CNMD
  • Listed entityCONMED Corporation
  • Exchange sectorHealth technology
  • ISINUS2074101013
  • Share price$45.55 (+0.42% on the day) · 2026-10-13
  • Market capitalisation$1.36B
  • Price to earnings24.6
  • EPS (diluted, trailing year)$1.85
  • Dividend yield0.44%
  • Volume (last session)521,743

Financials of CONMED

Figures of Linvatec India Private Limited, the primary company behind CONMED, for FY 2024. Revenue was ₹44.33 Cr (+38% year on year). Net profit was ₹1.23 Cr (3% margin). EBITDA was ₹4.07 Cr (9% margin). Revenue has grown at a compounded annual rate of +42% over three years and +17% over five years.

  • ₹44.33 CrRevenue · FY 2024 · +38% YoY
  • ₹1.23 CrNet profit · 3% margin
  • ₹4.07 CrEBITDA · 9% margin
  • ₹50 LakhPaid-up capital
  • 28Employees (provident fund records)
  • +42%Revenue CAGR, 3 years
  • +17%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$1.37B$47.0M$193.5M
2024$1.30B$132.4M$215.5M
2023$1.24B$64.5M$182.2M
2022$1.03B-$80.6M$133.4M
2021$1.02B$62.5M$166.2M

Balance sheet, profit and loss, cash flow and ratios of Linvatec India Private Limited are on its company page.

Premium access

Detailed financial statements for CONMED

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CONMED

CONMED has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Buffalo Filter, In2Bones and In2Bones USA.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of single use surgical instruments and orthopedic implants for use in lower extremity surgeries.
in2bones.comEcully, France2011Jun 2022••••
Plating and fixation systems are developed for orthopedic applications.
i2b-usa.comMemphis, United States2014May 2022••••
Surgical smoke evacuation solutions are provided by Buffalo Filter.
buffalofilter.comLancaster, United States1991Dec 2018$365M
Ride-hailing services are aggregated via app for Sheffield users.
citytaxis.comSheffield, United Kingdom2003Dec 2018••••
Products for minimally invasive surgery are developed and supplied.
surgiquest.com2006Nov 2015$265M
Visualization solutions for minimally invasive surgery are developed and marketed.
vikingsystems.comWestborough, United States1998Aug 2012$22.5M
Arthroscopy products and powered surgical instruments are developed.
linvatec.comLargo, United States1963Dec 1997$370M
Premium access

Complete acquisition details for CONMED

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of CONMED

11 dated milestones of CONMED across 35 years, from founding to its latest funding, stage changes and deals.

  1. Founded CONMED is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Linvatec.
  4. Funding First funding round of $150.0M.
  5. Acquisition Acquires Viking Systems.
  6. Acquisition Acquires SurgiQuest.
  7. Acquisition Acquires Sheffield City Taxis.
  8. Acquisition Acquires Buffalo Filter.
  9. Funding Latest funding round, Post-IPO, of $345.0M.
  10. Acquisition Acquires In2Bones USA.
  11. Acquisition Acquires In2Bones.

Competitors of CONMED

CONMED has 3 listed competitors in our database, 1 of them funded. They include GE Healthcare, Medtronic and Boston Scientific.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gehealthcare.com1892Chicago, United States$29.13M16,700
Materials management solutions are provided for healthcare organizations.
medtronic.com1949Minneapolis, United States1,114
Medical equipment for treating over 30 chronic diseases is developed.
bostonscientific.com1979Marlborough, United States63,359
Wide range of medical devices
Premium access

Detailed competitors of CONMED

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of CONMED

The website of CONMED (conmed.com) receives about 76.6K visits a month.

  • Monthly visits
    76.6K

    ▲ 18.2% vs previous month

Similar websites

Websites whose visitors overlap most with CONMED. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medtronic.com
100%
2.6M#22,622View details
stryker.com
99%
1.1M#56,352View details
karlstorz.com
85%
182.7K#222,356View details
covidien.com
84%
View details
smith-nephew.com
84%
296.7K#152,630View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for CONMED

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Diversified Medical Devices

3 companies that operate in the same segment as CONMED (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United StatesUSD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United StatesUSD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United StatesUSD 94.18 B139,800
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Conmed

Premium access

Complete news archive for CONMED

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CONMED

CONMED was founded in 1987 and raised its 1st funding round 17 years after it was founded.

CONMED is headquartered in Utica, United States. It is registered at Utica, New York, United States.

Curt Hartman is the CEO of CONMED, as recorded in our data.

CONMED has 3,900 employees.

The primary company behind CONMED, Linvatec India Private Limited, reported revenue of ₹44.33 Cr for FY 2024, up 38% year on year.

CONMED was established in 1987 in Utica, United States, as a medical device company. Emphasis is placed on research and development for manufacturing surgical instruments and equipment used in minimally invasive procedures. Products are applied across specialties including general surgery, urology, gynecology, colorectal, and gastroenterology. Operations center on supporting surgeons and physicians with tools for various therapeutic needs.

CONMED's top competitors include GE Healthcare, Medtronic and Boston Scientific.

CONMED offers AirSeal, BioBrace, and Argo Knotless.

Yes, CONMED is publicly traded on NYSE under the ticker symbol CNMD.

CONMED has made 7 acquisitions, including Buffalo Filter, In2Bones, and In2Bones USA.

CONMED has 2 investors. Key investors include Barclays, and J P Morgan Wealth Management.

CONMED operates through Linvatec India Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available